Related Experiment Video
Updated: Jun 21, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Treatment blood pressure targets for hypertension
Jose Agustin Arguedas1, Marco I Perez, James M Wright
1Depto de Farmacologia Clinica, Facultad de Medicina, Universidad de Costa Rica, San Pedro de Montes de Oca, Costa Rica.
Insights
Lowering blood pressure targets below standard levels does not reduce mortality or morbidity. This study found no significant benefits in major cardiovascular events or mortality when aiming for lower blood pressure (BP) goals.
Area of Science:
- Cardiology
- Hypertension Management
- Clinical Trials
Background:
- Standard clinical practice for hypertension involves blood pressure (BP) targets of ≤ 140-160/90-100 mmHg.
- Recent guidelines suggest lower BP targets, but their impact on mortality and morbidity is unclear.
Purpose of the Study:
- To evaluate if lower BP targets (≤ 135/85 mmHg) reduce mortality and morbidity compared to standard targets (≤ 140-160/90-100 mmHg).
Main Methods:
- Systematic electronic search of MEDLINE, EMBASE, and CENTRAL databases.
- Inclusion of randomized controlled trials comparing lower versus standard BP targets.
- Primary outcomes included total mortality, cardiovascular events, myocardial infarction, stroke, heart failure, and end-stage renal disease.
Main Results:
- Seven trials (22,089 subjects) compared diastolic BP targets; no trials compared systolic BP targets.
- Lowering BP targets did not significantly reduce total mortality, myocardial infarction, stroke, heart failure, major cardiovascular events, or end-stage renal disease.
- Sensitivity analyses in diabetic and renal disease patients also showed no benefit from lower BP targets.
Conclusions:
- Treating patients to lower than standard BP targets does not decrease mortality or morbidity.
- Further systematic reviews are underway for specific patient groups, including those with diabetes mellitus and chronic renal disease.
Background:
When treating elevated blood pressure, doctors need to know what blood pressure (BP) target they should try to achieve. The standard of clinical practice for some time has been = 140 - 160/ 90 - 100 mmHg. New guidelines are recommending BP targets lower than this standard. It is not known whether attempting to achieve targets lower than the standard reduces mortality and morbidity.
Objectives:
To determine if lower BP targets (= 135/85 mmHg) are associated with reduction in mortality and morbidity as compared with standard BP targets (= 140-160/ 90-100 mmHg).
Search Strategy:
Electronic search of MEDLINE (1966-2008), EMBASE (1980-2008), and CENTRAL (up to June 2008); references from review articles, clinical guidelines, and clinical trials.
Selection Criteria:
Randomized controlled trials comparing patients randomized to lower or to standard BP targets and providing data on any of the primary outcomes below.
Data Collection And Analysis:
Two reviewers (JAA, MIP) independently assessed the included trials and data entry. Primary outcomes were total mortality; total serious adverse events; total cardiovascular events; myocardial infarction, stroke, congestive heart failure and end stage renal disease. Secondary outcomes were achieved mean systolic and diastolic BP and withdrawals due to adverse effects.
Main Results:
No trials comparing different systolic BP targets were found. Seven trials (22,089 subjects) comparing different diastolic BP targets were included. Despite a -4/-3 mmHg greater achieved reduction in systolic/diastolic BP, p< 0.001, attempting to achieve "lower targets" instead of "standard targets" did not change total mortality (RR 0.92, 95% CI 0.86-1.15), myocardial infarction (RR 0.90, 95% CI 0.74-1.09), stroke (RR 0.99, 95% CI 0.79-1.25) , congestive heart failure (RR 0.88, 95% CI 0.59-1.32), major cardiovascular events (RR 0.94, 95% CI 0.83-1.07), or end-stage renal disease (RR 1.01, 95% CI 0.81-1.27). The net health effect of lower targets cannot be fully assessed due to lack of information regarding all total serious adverse events and withdrawals due to adverse effects in 6 of 7 trials. A sensitivity analysis in diabetic patients and in patients with chronic renal disease also did not show a reduction in any of the mortality and morbidity outcomes with lower targets as compared to standard targets.
Authors' Conclusions:
Treating patients to lower than standard BP targets, =140-160/90-100 mmHg, does not reduce mortality or morbidity. Because guidelines are recommending even lower targets for diabetes mellitus and chronic renal disease, we are currently conducting systematic reviews in those groups of patients.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension I: Introduction
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...